Missouri- and New Jersey-based drugmaker Nostrum Laboratories and its founder and CEO, Dr. Nirmal Mulye have agreed to pay a minimum of $3,825,000 – and up to $50 million if certain financial ...
A whistleblower action under the federal False Claims Act (31 U.S.C. §§ 3729 et seq.) against a U.S. pharmaceutical company has settled for an amount that can be as high as $50 million. The incident ...
NEW YORK, NY (IANS) – A pharmaceutical company and its Indian American chief have agreed to resolve allegations that they knowingly underpaid Medicaid rebates due for the company’s drug Nitrofurantoin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results